Trial Information

Summary: Efficacy and Safety/Tolerability of Methylphenidate Transdermal System (MTS) for Before-School Dysfunction in Children with Attention Deficit Hyperactivity Disorder (ADHD)

Does your child experience inattention, restlessness, distractibility, and/or hyperactivity? These symptoms may be signs of Attention Deficit Hyperactivity Disorder (ADHD). The Pediatric Psychopharmacology Unit at Massachusetts General Hospital is conducting a clinical research study looking at ADHD in children ages 6-12.

Evaluation, study visits and study medication are provided at no cost to participants.

For more information please call (617) 724-ADHD

Contact:

Kerry Brodziak
Massachusetts General Hospital
Pediatric Psychopharmacology
185 Alewife Brook Pkwy, Suite 2000
Cambridge, MA 02138
Telephone: 617-503-1043
Email:

Profile Page: Massachusetts General Hospital, Cambridge, MA

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 15, 2008 at 3:46:03 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA